Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SAFINAMIDE MESYLATE, with a corresponding US DMF Number 35096.
Remarkably, this DMF maintains an Active status since its submission on September 01, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 01, 2020, and payment made on September 22, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II